Mulinari, Holmberg & Ideland: Money, Money, Money? Politico-Moral Discourses of Stem Cell Research in a Grant Allocation Process
暂无分享,去创建一个
[1] Kaushik Sunder Rajan,et al. Biocapital: The Constitution of Postgenomic Life , 2006 .
[2] Sakari Tamminen,et al. Bio-objects life in the 21st century , 2012 .
[3] Charlotte Salter,et al. Governing innovation in the biomedicine knowledge economy: stem cell science in the USA , 2010 .
[4] G. Daley,et al. The promise and perils of stem cell therapeutics. , 2012, Cell stem cell.
[5] Intermingling Academic and Business Activities , 2009 .
[6] Carrie B. Sanders,et al. Reframing norms: boundary maintenance and partial accommodations in the work of academic technology transfer , 2010 .
[7] Huang Hoon Chng. Critical discourse analysis: The critical study of language: Norman Fairclough, London: Longman, 1995. £12.99 , 1996 .
[8] Philip Mirowski,et al. Introduction: STS and Neoliberal Science , 2010 .
[9] C. Waldby. Stem Cells, Tissue Cultures and the Production of Biovalue , 2002 .
[10] Shai Mulinari,et al. Regulating drug information in Europe: a pyrrhic victory for pharmaceutical industry critics? , 2013, Sociology of health & illness.
[11] S. Sismondo. An Introduction to Science and Technology Studies , 2003 .
[12] P. Cerny,et al. Paradoxes of the Competition State: The Dynamics of Political Globalization , 1997, Government and Opposition.
[13] Paul Martin,et al. From Bedside to Bench? Communities of Promise, Translational Research and the Making of Blood Stem Cells , 2008 .
[14] D. Pestre. The Technosciences between Markets, Social Worries and the Political: How to Imagine a Better Future? , 2005 .
[15] T. Caulfield. Stem Cell Research and Economic Promises , 2010, Journal of Law, Medicine & Ethics.
[16] Alexander Styhre,et al. Venturing into the Bioeconomy: Professions, innovation, identity , 2011 .
[17] Clare Williams,et al. Spaces of speech and places of performance: an outline of a geography of science approach to embryonic stem cell research and diabetes , 2008 .
[18] Sheila Slaughter,et al. Changes in intellectual property statutes and policies at a public university: Revising the terms of professional labor , 1993 .
[19] A. Webster,et al. Bio-objects and the bio-objectification process , 2011, Croatian medical journal.
[20] Philip Mirowski,et al. Science Bought and Sold: Essays in the Economics of Science , 2002 .
[21] Lorraine Daston,et al. The Moral Economy of Science , 1995, Osiris.
[22] N. Brown,et al. Commercial development of stem cell technology: lessons from the past, strategies for the future. , 2006, Regenerative medicine.
[23] D. Braun,et al. The role of funding agencies in the cognitive development of science , 1998 .
[24] Anke C. Plagnol,et al. Industry perceptions of barriers to commercialization of regenerative medicine products in the UK. , 2009, Regenerative medicine.
[25] B. Salter,et al. Bioethics and the Global Moral Economy , 2007 .
[26] Janus Hansen,et al. Governing bio-objects: a research agenda , 2012, Croatian medical journal.
[27] R. Wodak. Critical Discourse Analysis , 2003 .
[28] Stuart Hall. Introduction: Who Needs ‘Identity’? , 2011 .
[29] Sergio Sismondo,et al. Ghosts in the Machine , 2009, Social studies of science.
[30] B. Salter. Governing stem cell science in China and India: emerging economies and the global politics of innovation , 2008 .
[31] Andreas Strotmann,et al. Commercialization and collaboration: competing policies in publicly funded stem cell research? , 2010, Cell stem cell.
[32] Loet Leydesdorff,et al. A Triple Helix of University—Industry—Government Relations , 1998, Scientometrics.
[33] Sheila Slaughter,et al. Academic capitalism and the new economy : markets, state, and higher education , 2009 .
[34] S. Schwartzman,et al. The New Production of Knowledge: The Dynamics of Science and Research in Contemporary Societies , 1994 .
[35] Philip Mirowski,et al. The Contract Research Organization and the Commercialization of Scientific Research , 2005, Social studies of science.
[36] T. Caulfield,et al. Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine. , 2008, Cell stem cell.
[37] Andrew Webster,et al. Standardizing the Unknown: Practicable Pluripotency as Doable Futures , 2008 .
[38] Henry Etzkowitz,et al. Universities and the global knowledge economy , 1997 .
[39] Annika Rickne,et al. On the position and opportunities for Sweden within the field of Tissue Engineering & Regenerative Medicine, TERM, Report to the Swedish Governmental Agency for Innovation Systems , 2008 .
[40] D. Hess,et al. Science and neoliberal globalization: a political sociological approach , 2011 .
[41] S. Sörlin,et al. Shaping strategic research: power, resources, and interests in Swedish research policy , 2007 .
[42] R. Kohler,. Lords of the fly: Drosophila genetics and the experimental life. , 1995 .
[43] D. Haraway,et al. Modest_Witness@Second_Millennium. FemaleMan_Meets_OncoMouse , 1997 .
[44] Henrik Loodin,et al. The politics of life itself Biomedicine, power, and subjectivity in the twenty-first century , 2009 .
[45] N. Brown. Beasting the Embryo: The Metrics of Humanness in the Transpecies Embryo Debate , 2009 .
[46] Bob Jessop,et al. The Future of the Capitalist State , 2002 .
[47] A. Blaser,et al. The Global Politics of Human Embryonic Stem Cell Science: Regenerative Medicine in Transition , 2010, Politics and the Life Sciences.